Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
Abstract Purpose To evaluate the safety, tolerability, and preliminary efficacy of multiple doses of pegylated irinotecan (JK1201I) as a second‐line monotherapy for treating small‐cell lung cancer (SCLC) patients. Methods According to the “3 + 3” dose‐escalation principle, patients received intraven...
Saved in:
Main Authors: | Jieran Long, Xuefei Li, Lin Wu, Guohua Yu, Aimin Zang, Yanqiu Zhao, Jinsheng Shi, Ligong Nie, Xuan Zhao, Jian Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70059 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A narrative review of long-term inorganic iodine monotherapy for Graves’ disease with a historical relationship between iodine and thyroid
by: Natsuko Watanabe
Published: (2025-01-01) -
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer
by: Johan Staby Olsén, et al.
Published: (2025-03-01) -
Usefulness of perampanel as initial monotherapy in children with non-lesional focal epilepsy
by: Hideaki Kanemura, et al.
Published: (2025-03-01) -
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01) -
Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis
by: Biqiong Pan, et al.
Published: (2025-02-01)